Adaptive Biotechnologies Corporation
ADPT
$17.53
$0.754.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.68M | -59.50M | -79.49M | -121.23M | -141.84M |
| Total Depreciation and Amortization | 16.94M | 17.83M | 18.09M | 18.27M | 18.77M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.62M | 53.45M | 53.14M | 53.91M | 61.01M |
| Change in Net Operating Assets | -47.92M | -57.77M | -52.26M | -31.42M | -23.29M |
| Cash from Operations | -27.04M | -45.99M | -60.53M | -80.47M | -85.34M |
| Capital Expenditure | -2.50M | -2.96M | -2.40M | -2.34M | -3.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.02M | 40.91M | 70.72M | 58.66M | 62.27M |
| Cash from Investing | 21.52M | 37.95M | 68.32M | 56.33M | 58.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 32.45M | 30.40M | 8.87M | 7.23M | 5.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.45M | 30.40M | 8.87M | 7.23M | 5.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.93M | 22.37M | 16.66M | -16.92M | -20.84M |